255 related articles for article (PubMed ID: 12934714)
21. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
Abati E; Bresolin N; Comi G; Corti S
Expert Opin Ther Targets; 2020 Apr; 24(4):295-310. PubMed ID: 32125907
[No Abstract] [Full Text] [Related]
22. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.
Towne C; Raoul C; Schneider BL; Aebischer P
Mol Ther; 2008 Jun; 16(6):1018-25. PubMed ID: 18414477
[TBL] [Abstract][Full Text] [Related]
23. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
Wang H; Yang B; Qiu L; Yang C; Kramer J; Su Q; Guo Y; Brown RH; Gao G; Xu Z
Hum Mol Genet; 2014 Feb; 23(3):668-81. PubMed ID: 24108104
[TBL] [Abstract][Full Text] [Related]
24. Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model.
Saito Y; Yokota T; Mitani T; Ito K; Anzai M; Miyagishi M; Taira K; Mizusawa H
J Biol Chem; 2005 Dec; 280(52):42826-30. PubMed ID: 16221675
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi.
Towne C; Aebischer P
Methods Mol Biol; 2009; 555():87-108. PubMed ID: 19495690
[TBL] [Abstract][Full Text] [Related]
26. siRNAs meet their match.
Potash J
Nat Methods; 2006 Nov; 3(11):876. PubMed ID: 17124734
[TBL] [Abstract][Full Text] [Related]
27. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Hernández S; Piedrafita L; Hereu M; Esquerda JE
J Neuropathol Exp Neurol; 2013 Jul; 72(7):646-61. PubMed ID: 23771221
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid.
Jiang HZ; Wang SY; Yin X; Jiang HQ; Wang XD; Wang J; Wang TH; Qi Y; Yang YQ; Wang Y; Zhang CT; Feng HL
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999308
[TBL] [Abstract][Full Text] [Related]
29. RNA interference protects against ALS in mouse model.
Burton A
Lancet Neurol; 2005 May; 4(5):274-5. PubMed ID: 15861555
[No Abstract] [Full Text] [Related]
30. AAV6-mediated gene silencing fALS short.
Mandel RJ; Lowenstein PR; Byrne BJ
Mol Ther; 2011 Feb; 19(2):231-3. PubMed ID: 21289637
[No Abstract] [Full Text] [Related]
31. Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.
Wu R; Wang H; Xia X; Zhou H; Liu C; Castro M; Xu Z
Antioxid Redox Signal; 2009 Jul; 11(7):1523-34. PubMed ID: 19344276
[TBL] [Abstract][Full Text] [Related]
32. RNAi silencing in mouse models of neurodegenerative diseases.
Farah MH
Curr Drug Deliv; 2007 Apr; 4(2):161-7. PubMed ID: 17456035
[TBL] [Abstract][Full Text] [Related]
33. Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfalls.
Trochet D; Prudhon B; Vassilopoulos S; Bitoun M
Curr Gene Ther; 2015; 15(5):503-10. PubMed ID: 26264709
[TBL] [Abstract][Full Text] [Related]
34. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.
Kaur SJ; McKeown SR; Rashid S
Gene; 2016 Feb; 577(2):109-18. PubMed ID: 26657039
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates.
Borel F; Gernoux G; Cardozo B; Metterville JP; Toro Cabrera GC; Song L; Su Q; Gao GP; Elmallah MK; Brown RH; Mueller C
Hum Gene Ther; 2016 Jan; 27(1):19-31. PubMed ID: 26710998
[TBL] [Abstract][Full Text] [Related]
36. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
37. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice.
Towne C; Setola V; Schneider BL; Aebischer P
Mol Ther; 2011 Feb; 19(2):274-83. PubMed ID: 21102563
[TBL] [Abstract][Full Text] [Related]
39. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions.
Kunst CB; Mezey E; Brownstein MJ; Patterson D
Nat Genet; 1997 Jan; 15(1):91-4. PubMed ID: 8988176
[TBL] [Abstract][Full Text] [Related]
40. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.
Miller TM; Kim SH; Yamanaka K; Hester M; Umapathi P; Arnson H; Rizo L; Mendell JR; Gage FH; Cleveland DW; Kaspar BK
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19546-51. PubMed ID: 17164329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
